GEN Exclusives

More »

Best of the Web

More »
Jun 01, 2011 (Vol. 31, No. 11)

  • Many browse options, different classes of drugs
  • Nothing major

If you have any interest in pharmaceuticals, then you can “bank” on the fact that you’ll find DrugBank to be a fantastic resource. Of the “molecule-target interaction” variety, DrugBank is different from many of the other databases out there in its emphasis on pharmaceutical data. It contains FDA-approved biotech (protein/peptide) drugs, FDA-approved small molecule drugs, and a large number of experimental drugs. Together, these categories represent over 10,000 entries. As useful as it is to search databases, I always appreciate an option to browse. DrugBank, in fact, gives me (and you!) six such options: browse by drug name, therapeutic category, interacting gene/enzyme, pathway, chemical class, or association (target, enzyme, carrier, or transporter). For each compound, general chemical information is provided in addition to taxonomy, pharmacology, pharmacoeconomics, references, drug interactions, and targets.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »